Not a stand-alone test. Order in conjunction with Herpes Simplex Virus Type 1 Glycoprotein G-Specific Antibody, IgG by CIA (0050292).
Semi-Quantitative Chemiluminescent Immunoassay
New York DOH Approval Status
Serum Separator Tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Contaminated, heat-inactivated, grossly hemolyzed, lipemic, or severely icteric specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|Effective February 18, 2020
|0.89 IV or less||Negative - No significant level of detectable IgG antibody to HSV type 2 glycoprotein G.|
|0.90-1.09 IV||Equivocal - Questionable presence of IgG antibody to HSV type 2 glycoprotein G. Repeat testing in 10-14 days may be helpful.|
|1.10 IV or greater||Positive - IgG antibody to HSV type 2 glycoprotein G detected, which may indicate a current or past HSV infection.|
Individuals infected with HSV may not exhibit detectable IgG antibody to type-specific HSV antigens 1 and 2 in the early stages of infection. Detection of antibody presence in these cases may only be possible using a non-type specific screening test.
For CSF specimens refer to Herpes Simplex Virus Type 2 Glycoprotein G-Specific Antibody, IgG by ELISA, CSF (ARUP test code 0050359).
|Component Test Code*||Component Chart Name||LOINC|
|0050294||HSV 2 Glycoprotein G Antibody, IgG||42338-4|
- Herpes Simplex glycoprotein G
- HSV 2 typing
- HSV Type 2 IgG Specific Ab
- HSV typing